Jeffrey A. Albaugh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jeffrey A. Albaugh has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Brittany Adamic
Pediatric Urology, Section of Urology, Department of Surgery, UCMC and Comer Children's Hospital, The University of Chicago Biological Sciences Division and Pritzker School of Medicine, Chicago, IL, USA
1 shared publication - Brittany Lapin
Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, Illinois
1 shared publication - Cecilia Chang
Division of Urology, Department of Surgery, Northshore University Health System, Evanston, USA
1 shared publication Dana M. Hayden
Division of Colon and Rectal Surgery, Department of Surgery, Loyola University Medical Center, Maywood, Illinois
1 shared publication- Jacqueline Petkewicz
John and Carol Walter Center for Urological Health, NorthShore University HealthSystem, 2180 Pfingsten Road, Suite 3000, Glenview, Illinois, 60026, USA
1 shared publication - Joshua Aizen
University of Chicago Medical Center, Chicago, USA
1 shared publication
Latest Publications
- 1 August 2020
- Published by Springer Nature
- p. 85-118
Erectile Dysfunction: Identification, Assessment, Treatment, and Follow-Up
- 1 August 2020
- Published by Springer Nature
- p. 85-118
Erectile Dysfunction: Identification, Assessment, Treatment, and Follow-Up
- Open Access
- 7 October 2019
- Published by Springer Nature in BMC Urology
- Vol. 19 (1) , 1-10
Adherence and barriers to penile rehabilitation over 2 years following radical prostatectomy
Background: A variety of penile rehabilitation (PR) therapies are available to improve post-prostatectomy erectile dysfunction (ED) with mixed results. It is uncertain how adherent men are to PR therapies. The aim of this study is to determine adherence to and identify barriers to PR treatment. Methods: A longitudinal cross-sectional approach was used in men who underwent radical prostatectomy over 2 years. Men were instructed to take a PDE5 inhibitor (PDE5i) three times per week, and if required, utilize a vacuum constriction device (VCD) daily. Outcomes were measured by multiple validated questionnaires. In addition, penile stretched length, side effects, compliance to PR regimen & barriers to participation were documented. Results: Seventy-seven patients were enrolled, however only 49 completed evaluation at 3 or more timepoints and were included in analysis. This cohort was an average age of 58.1 years (±7.7), had robotic laparoscopic radical prostatectomy (91.7%), and had bilateral nerve sparing procedures (95.8%). Majority (62.5%) reported normal SHIM pre-operatively, however 79% used PDE5i. Erectile function as measured by IIEF and Erection Hardness Rating were negatively affected post-operatively, with gradual improvement in parameters throughout the 24 month follow up. Of the participants who had normal pre-op SHIM, only 23.1 and 28.6% regained baseline function at 1 and 2 years, respectively. Orgasm was significantly diminished immediately post-operatively, however, at the end of the study period only 37% of men reported diminished climax and no men reported absent orgasm. Adherence to penile rehabilitation therapies declined overtime. Men took oral PDE5i on average 2.3 times weekly at 12 and 24 months (p < 0.001). Men used the VCD 2.3–3.9 days a week, which declined overtime (p = 0.014). Conclusions: Improvement in erectile and orgasm parameters was observed over time, but most men did not return to baseline function. Despite comprehensive instructions and a frequent follow up schedule, PDE5i and VCD adherence was poor. High attrition rates were noted with only 55.8% of men remaining at 12 months and 45% of men completing 24 months. The most common barriers to PR adherence were cost, inconvenience and perceived ineffectiveness.
- 7 October 2019
- Published by Springer Nature in BMC Urology
- Vol. 19 (1) , 1-10
Open AccessAdherence and barriers to penile rehabilitation over 2 years following radical prostatectomy
Background: A variety of penile rehabilitation (PR) therapies are available to improve post-prostatectomy erectile dysfunction (ED) with mixed results. It is uncertain how adherent men are to PR therapies. The aim of this study is to determine adherence to and identify barriers to PR treatment. Methods: A longitudinal cross-sectional approach was used in men who underwent radical prostatectomy over 2 years. Men were instructed to take a PDE5 inhibitor (PDE5i) three times per week, and if required, utilize a vacuum constriction device (VCD) daily. Outcomes were measured by multiple validated questionnaires. In addition, penile stretched length, side effects, compliance to PR regimen & barriers to participation were documented. Results: Seventy-seven patients were enrolled, however only 49 completed evaluation at 3 or more timepoints and were included in analysis. This cohort was an average age of 58.1 years (±7.7), had robotic laparoscopic radical prostatectomy (91.7%), and had bilateral nerve sparing procedures (95.8%). Majority (62.5%) reported normal SHIM pre-operatively, however 79% used PDE5i. Erectile function as measured by IIEF and Erection Hardness Rating were negatively affected post-operatively, with gradual improvement in parameters throughout the 24 month follow up. Of the participants who had normal pre-op SHIM, only 23.1 and 28.6% regained baseline function at 1 and 2 years, respectively. Orgasm was significantly diminished immediately post-operatively, however, at the end of the study period only 37% of men reported diminished climax and no men reported absent orgasm. Adherence to penile rehabilitation therapies declined overtime. Men took oral PDE5i on average 2.3 times weekly at 12 and 24 months (p < 0.001). Men used the VCD 2.3–3.9 days a week, which declined overtime (p = 0.014). Conclusions: Improvement in erectile and orgasm parameters was observed over time, but most men did not return to baseline function. Despite comprehensive instructions and a frequent follow up schedule, PDE5i and VCD adherence was poor. High attrition rates were noted with only 55.8% of men remaining at 12 months and 45% of men completing 24 months. The most common barriers to PR adherence were cost, inconvenience and perceived ineffectiveness.
- Open Access
- 15 June 2017
- Published by Springer Nature in BMC Urology
- Vol. 17 (1) , 1-9
Life after prostate cancer treatment: a mixed methods study of the experiences of men with sexual dysfunction and their partners
Prostate cancer is the most common non-skin cancer in men and sexual dysfunction is the most frequently reported long-term side effect of prostate cancer surgery or radiation. The aim of this study was to examine the experiences of men with sexual dysfunction and their partners following prostate cancer treatment. Men with sexual dysfunction from either surgical removal or radiation therapy 1-5 years after treatment were interviewed, as well as their partners. A mixed method design was used to determine the lived experience of men with sexual dysfunction. Open-ended questions guided the interviews. Twenty seven men completed the study with a mean age of 61 years (SD = 8.0; range = 44-77 years). Nine partners also participated. The majority of men (92.6%) had surgery. The average time from treatment to the interview was 23.5 months (SD = 11.7). Themes were frustration with sexual dysfunction, importance of support and understanding from others, depression and anxiety related to sexual dysfunction, importance of intimacy with partner, factors that impact treatment satisfaction, and education and comprehensive information about sex. Prostate cancer survivors and partners need accurate information about sexual side effects before during and after treatment. Men and partners required individualized help and guidance to manage sexual dysfunction. Support and understanding from partners, family, and others was also identified as an important aspect of healing and adjustment after prostate cancer treatment. Prostate cancer education/support groups played a key role in helping men and partners gain advocacy, education, and support. Psychological problems such as depression and anxiety need to be identified and addressed in men after prostate cancer treatment. Men and partners need assistance in understanding and navigating their way through intimacy to move forward with connectedness in their relationship. Satisfaction with treatment and with providers is dependent on patient education and understanding of all aspects of prostate cancer treatment including sexual side effects and incontinence.
- 15 June 2017
- Published by Springer Nature in BMC Urology
- Vol. 17 (1) , 1-9
Open AccessLife after prostate cancer treatment: a mixed methods study of the experiences of men with sexual dysfunction and their partners
Prostate cancer is the most common non-skin cancer in men and sexual dysfunction is the most frequently reported long-term side effect of prostate cancer surgery or radiation. The aim of this study was to examine the experiences of men with sexual dysfunction and their partners following prostate cancer treatment. Men with sexual dysfunction from either surgical removal or radiation therapy 1-5 years after treatment were interviewed, as well as their partners. A mixed method design was used to determine the lived experience of men with sexual dysfunction. Open-ended questions guided the interviews. Twenty seven men completed the study with a mean age of 61 years (SD = 8.0; range = 44-77 years). Nine partners also participated. The majority of men (92.6%) had surgery. The average time from treatment to the interview was 23.5 months (SD = 11.7). Themes were frustration with sexual dysfunction, importance of support and understanding from others, depression and anxiety related to sexual dysfunction, importance of intimacy with partner, factors that impact treatment satisfaction, and education and comprehensive information about sex. Prostate cancer survivors and partners need accurate information about sexual side effects before during and after treatment. Men and partners required individualized help and guidance to manage sexual dysfunction. Support and understanding from partners, family, and others was also identified as an important aspect of healing and adjustment after prostate cancer treatment. Prostate cancer education/support groups played a key role in helping men and partners gain advocacy, education, and support. Psychological problems such as depression and anxiety need to be identified and addressed in men after prostate cancer treatment. Men and partners need assistance in understanding and navigating their way through intimacy to move forward with connectedness in their relationship. Satisfaction with treatment and with providers is dependent on patient education and understanding of all aspects of prostate cancer treatment including sexual side effects and incontinence.
- 22 May 2017
- Published by Georg Thieme Verlag KG in Clinics in Colon and Rectal Surgery
- Vol. 30 (03) , 201-206
Sexual Dysfunction and Intimacy for Ostomates
Sex and intimacy presents special challenges for the ostomate. Since some colorectal surgery patients will require either temporary or permanent stomas, intimacy and sexuality is a common issue for ostomates. In addition to the stoma, nerve damage, radiotherapy, and chemotherapy are often used in conjunction with stoma creation for cancer patients, thereby adding physiological dysfunction to the personal psychological impact of the stoma, leading to sexual dysfunction. The purpose of this paper is to describe the prevalence, etiology, and the most common types of sexual dysfunction in men and women after colorectal surgery and particularly those patients with stomas. In addition, treatment strategies for sexual dysfunction will also be described.
- 22 May 2017
- Published by Georg Thieme Verlag KG in Clinics in Colon and Rectal Surgery
- Vol. 30 (03) , 201-206
Sexual Dysfunction and Intimacy for Ostomates
Sex and intimacy presents special challenges for the ostomate. Since some colorectal surgery patients will require either temporary or permanent stomas, intimacy and sexuality is a common issue for ostomates. In addition to the stoma, nerve damage, radiotherapy, and chemotherapy are often used in conjunction with stoma creation for cancer patients, thereby adding physiological dysfunction to the personal psychological impact of the stoma, leading to sexual dysfunction. The purpose of this paper is to describe the prevalence, etiology, and the most common types of sexual dysfunction in men and women after colorectal surgery and particularly those patients with stomas. In addition, treatment strategies for sexual dysfunction will also be described.
- 21 January 2014
- Published by Wiley in International Journal of Urological Nursing
- Vol. 8 (1) , 38-43
Female sexual dysfunction
Female sexual dysfunction is a common problem, yet it is often under‐treated. Sexual function is an integral part of the human experience and sexual dysfunction can negatively impact quality of life, yet many patients suffer in silence with their problems. This article provides a common case scenario, along with information on prevalence of female sexual dysfunction, definitions and classifications of female sexual dysfunction as well as some of the treatment options available.
- 21 January 2014
- Published by Wiley in International Journal of Urological Nursing
- Vol. 8 (1) , 38-43
Female sexual dysfunction
Female sexual dysfunction is a common problem, yet it is often under‐treated. Sexual function is an integral part of the human experience and sexual dysfunction can negatively impact quality of life, yet many patients suffer in silence with their problems. This article provides a common case scenario, along with information on prevalence of female sexual dysfunction, definitions and classifications of female sexual dysfunction as well as some of the treatment options available.